Explore 3 Stock Ideas & Industry Insights Download Free Report
The Defiance Daily Target 2X Long ORCL ETF (NASDAQ: ORCX) seeks daily investment results, before fees and expenses, of 200% (2x long) of the daily performance of Oracle Corporation. The fund is an actively managed exchange-traded fund designed to deliver twice the daily percentage gain of ORCL’s stock price.

Oracle Corporation is a global leader in enterprise software, cloud computing, and database management systems. The company provides mission-critical infrastructure and applications used by businesses worldwide. Oracle benefits from recurring revenue streams through cloud subscriptions and enterprise contracts, but its stock performance is influenced by cloud growth, competition with hyperscalers, and broader technology sector trends.
Traders looking to capitalize on short-term upward movements in ORCL shares can use the Defiance Daily Target 2X Long ORCL ETF as a leveraged tool to express a bullish view.
The ETF has a focused and leveraged objective:
• To seek daily investment results, before fees and expenses, corresponding to two times (2x) the daily performance of Oracle Corporation.
This ETF is not intended for long-term investors. It is a specialized, high-risk instrument designed for experienced traders who understand leverage and actively manage positions.
Intended Uses
Key Considerations and Risks
Technical Price Chart


Conclusion
The Defiance Daily Target 2X Long ORCL ETF (ORCX) is a tactical trading instrument for investors seeking to capitalize on short-term bullish movements in Oracle Corporation. By offering 2x daily leveraged exposure, it enables traders to amplify gains when ORCL stock rises.
However, due to daily leverage resets, derivative exposure, and amplified volatility, ORCX carries significant risk. It requires active monitoring, disciplined execution, and a clear short-term strategy, making it more suitable for experienced traders rather than long-term investors.
Note 1: Past performance is not a reliable indicator of future performance.
Note 2: Reference data for price, technical indicators, support, and resistance levels is as of April 14 , 2026 and partly sourced from REFINITIV.
Note 3: Investment decisions should consider an individual’s risk appetite, upside potential, holding period, and prior holdings.
Note 4: Kalkine reports are based on prices captured from NASDAQ, NYSE, and/or REFINITIV, which may have a 15-20 minute lag. Future results may not be consistent with this report, and information is subject to change without notice.
The advice given by Kalkine Canada Advisory Services Inc. and provided on this website is general information only and it does not take into account your investment objectives, financial situation and the particular needs of any particular person. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. The website www.kalkine.ca is published by Kalkine Canada Advisory Services Inc. The link to our Terms & Conditions has been provided please go through them. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.
Past performance is not a reliable indicator of future performance.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Start Your 7-Days Free Trial Today!
Hi! How can we help you today?
Loading…